Last update 08 May 2025

VGO-Cs01p

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
NK cell derived from human embryonic stem cells(Shanghai Vitalgen Biopharma)
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
CD7 Positive T-Cell LeukemiaRefractory T Acute Lymphoblastic Leukemia
Inactive Indication-
Originator Organization
Shanghai Vitalgen Biopharma Co., Ltd.Shanghai Vitalgen Biopharma Co., Ltd.
Active Organization
Shanghai Vitalgen Biopharma Co., Ltd.Shanghai Vitalgen Biopharma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VGO-Cs01p
NCT06849401
/ Not yet recruitingEarly Phase 1IIT
A Single-arm, Open Label Clinical Study to Evaluate the Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia
100 Clinical Results associated with VGO-Cs01p
Login to view more data
100 Translational Medicine associated with VGO-Cs01p
Login to view more data
100 Patents (Medical) associated with VGO-Cs01p
Login to view more data
100 Deals associated with VGO-Cs01p
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD7 Positive T-Cell LeukemiaPhase 1-
Shanghai Vitalgen Biopharma Co., Ltd.Shanghai Vitalgen Biopharma Co., Ltd.
01 Feb 2025
Refractory T Acute Lymphoblastic LeukemiaPhase 1-
Shanghai Vitalgen Biopharma Co., Ltd.Shanghai Vitalgen Biopharma Co., Ltd.
01 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free